Search results
Emergency Access to Drug Technologies is a mechanism for financing drugs in situations where the prolongation of patient survival or significant improvement to his/her health can be obtained and when all available reimbursable drug technologies have been exhausted. It was launched on 23 July 2017.
These Regulations consolidate the law of the United Kingdom concerning medicinal products for human use (“products”) in respect of the topics described below.
A temporary emergency marketing authorisation at EU level will be introduced for public health emergencies where there is a major interest in developing and authorising safe and effective medicines as quickly as possible.
WHO guidelines on controlled medicines in emergencies outline simplified control measures for the cross-border trade of controlled medicines during humanitarian emergencies. They have been adapted into operational terms in the Inter-Agency Emergency Health Kit guidance.
Persons authorised by licences granted under regulation 5 of the Misuse of Drugs Regulations 2001 M9 or regulation 5 of the Misuse of Drugs Regulations (Northern Ireland) 2002 M10 to supply a...
8 wrz 2021 · Internationally controlled medicines such as morphine, diazepam and midazolam listed as WHO essential medicines, are vital for the management of pain, palliative care, surgical care and anesthesia, and treatment of drug-use disorders, mental health and neurological conditions. Shortages impact countries of all income levels.
FDA on Signing of the COVID-19 Emergency Relief Bill, Including Landmark Over-the-Counter Drug Reform and User Fee Legislation. On Friday, the President signed into law a $2 trillion...
